Semi-Annual Consolidated Statement Of Income

OncoTherapy Science, Inc. - Filing #7720896

Concept 2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
12,928,000 JPY
13,450,000 JPY
JPY
13,450,000 JPY
521,000 JPY
Ordinary profit (loss)
-717,416,000 JPY
-590,071,000 JPY
Extraordinary income
18,179,000 JPY
21,916,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
67,198,000 JPY
69,631,000 JPY
Profit (loss) before income taxes
-699,236,000 JPY
-568,155,000 JPY
Operating profit (loss)
-147,861,000 JPY
-655,612,000 JPY
-57,258,000 JPY
-712,870,000 JPY
-507,751,000 JPY
-593,171,000 JPY
Non-operating income
Interest income
209,000 JPY
339,000 JPY
Non-operating income
209,000 JPY
3,124,000 JPY
Income taxes - current
1,371,000 JPY
1,134,000 JPY
Income taxes - deferred
-396,000 JPY
-1,045,000 JPY
Non-operating expenses
Non-operating expenses
4,754,000 JPY
24,000 JPY
Income taxes
975,000 JPY
88,000 JPY
Extraordinary income
Profit (loss)
-700,211,000 JPY
-568,243,000 JPY
Profit (loss) attributable to non-controlling interests
-53,105,000 JPY
JPY
Profit (loss) attributable to owners of parent
-647,106,000 JPY
-568,243,000 JPY
Other comprehensive income
Foreign currency translation adjustment
182,000 JPY
-506,000 JPY
Other comprehensive income
182,000 JPY
-506,000 JPY
Comprehensive income
-700,029,000 JPY
-568,750,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-646,923,000 JPY
-568,750,000 JPY
Comprehensive income attributable to non-controlling interests
-53,105,000 JPY
JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.